These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

941 related items for PubMed ID: 29171073

  • 1. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S.
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques.
    Tian D, Uda A, Ami Y, Hotta A, Park ES, Nagata N, Iwata-Yoshikawa N, Yamada A, Hirayama K, Miura K, Koyama Y, Azaki M, Morikawa S.
    Sci Rep; 2019 Jun 24; 9(1):9193. PubMed ID: 31235714
    [Abstract] [Full Text] [Related]

  • 3. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 4. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W.
    PLoS One; 2013 May 10; 8(11):e78671. PubMed ID: 24236032
    [Abstract] [Full Text] [Related]

  • 12. Role of pathogenicity determinant protein C (PdpC) in determining the virulence of the Francisella tularensis subspecies tularensis SCHU.
    Uda A, Sekizuka T, Tanabayashi K, Fujita O, Kuroda M, Hotta A, Sugiura N, Sharma N, Morikawa S, Yamada A.
    PLoS One; 2014 May 10; 9(2):e89075. PubMed ID: 24558472
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S, Byström M, Chen W, Forsman M, Golovliov I, Johansson A, Kelly J, Lindgren H, Svensson K, Zingmark C, Conlan W, Sjöstedt A.
    Infect Immun; 2005 Dec 10; 73(12):8345-52. PubMed ID: 16299332
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.
    Vaccine; 2009 Sep 18; 27(41):5554-61. PubMed ID: 19651173
    [Abstract] [Full Text] [Related]

  • 17. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
    Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN.
    Clin Vaccine Immunol; 2014 Feb 18; 21(2):212-26. PubMed ID: 24351755
    [Abstract] [Full Text] [Related]

  • 18. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA.
    Infect Immun; 2013 May 18; 81(5):1550-61. PubMed ID: 23439306
    [Abstract] [Full Text] [Related]

  • 19. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W.
    Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834
    [Abstract] [Full Text] [Related]

  • 20. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.
    Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.